Australia's TGA consults on proposed overhaul of OTC drug guidelines
This article was originally published in SRA
Executive Summary
Australia's Therapeutic Goods Administration is inviting comments on its proposal to substantially revise its guidance document for over-the-counter medicines1. The revisions are being made to clarify the data requirements for submitting OTC medicine applications to the TGA and to provide guidance on OTC drug market authorisation processes that are also currently being reviewed.
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.